Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials
Journal of Internal Medicine · 2025-12 · 298 (6) · 711-717
DOI: 10.1111/joim.20107 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Internal Medicine, online erschienen am 07.07.2025. Verfasst von Sining Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Colchicine, Cardiovascular Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Methods
We systematically searched major databases up to March 2025 for RCTs comparing colchicine to placebo over a treatment duration of ≥12 months, reporting major adverse cardiovascular events (MACEs). Both fixed‐ and random‐effects models were used to compute pooled risk ratios (RRs) and 95% confidence intervals.
Results
Six RCTs comprising 21,774 patients were included. Colchicine significantly reduced the risk of MACEs (RR 0.74 [0.60–0.92]) and specific components of primary outcome (myocardial infarction, RR 0.85 [0.73–0.98]; stroke, RR 0.79 [0.65–0.95]), with no significant effect on cardiac death and revascularization.
Conclusion
These results support the efficacy of low‐dose colchicine in reducing MACEs when added to standard care for at least 12 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
- IRCCS MultiMedica, Sesto San Giovanni (MI), Italy.
Zitieren
APA
Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2025). Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials. Journal of Internal Medicine, 298(6), 711-717. https://doi.org/10.1111/joim.20107
Vancouver
Xie S, Galimberti F, Olmastroni E, Catapano AL, Casula M. Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials. Journal of Internal Medicine. 2025;298(6):711-717. doi:10.1111/joim.20107
BibTeX
@article{Xie2025,
author = {Xie, Sining and Galimberti, Federica and Olmastroni, Elena and Catapano, Alberico L and Casula, Manuela},
title = {Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials},
journal = {Journal of Internal Medicine},
year = {2025},
volume = {298},
number = {6},
pages = {711--717},
doi = {10.1111/joim.20107}
}
EUVIMED